RecruitingNCT05461664

Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

Studying Gastrointestinal stromal tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Xinhua Zhang, MD
Principal Investigator
Xinhua Zhang, PhD
First affiliated hosptial,Sun Yat-sen university
Enrollment
74 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

Peking University Cancer Hospital & Institute · Fudan University · Peking University People's Hospital · Chinese PLA General Hospital · Xiangya Hospital of Central South University · Peking University Shenzhen Hospital · Nanfang Hospital, Southern Medical University · West China Hospital · Jiangsu Cancer Institute & Hospital · Shanghai Zhongshan Hospital · Sun Yat-Sen University Cancer Center · Xijing Hospital · Shengjing Hospital · Shanghai Jiao Tong University School of Medicine · Liaoning Cancer Hospital & Institute · Sixth Affiliated Hospital, Sun Yat-sen University · Fujian Medical University Union Hospital · Cancer Hospital of Guangxi Medical University · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · First Affiliated Hospital of Chongqing Medical University · Chongqing University Cancer Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05461664 on ClinicalTrials.gov

Other trials for Gastrointestinal stromal tumor

Additional recruiting or active studies for the same condition.

See all trials for Gastrointestinal stromal tumor →

← Back to all trials